Pacific Biosciences Of California (PACB) Receivables (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Receivables of $29.4 million for Q1 2026, down 7.25% year-over-year from $31.6 million in Q1 2025, and down 17.2% quarter-over-quarter from $35.4 million in Q4 2025.
Pacific Biosciences Of California (PACB) Receivables (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Receivables history runs 17 years deep, the most recent figure standing at $29.4 million for Q1 2026.
- In Q1 2026, Receivables fell 7.25% year-over-year to $29.4 million; the TTM figure through Mar 2026 stood at $29.4 million (down 7.25% YoY), while the FY2025 annual figure was $35.4 million, up 28.79% from the prior year.
- Receivables for Q1 2026 stood at $29.4 million, down from $35.4 million in the prior quarter.
- The five-year high for Receivables was $36.6 million in Q4 2023, with the low at $18.8 million in Q4 2022.
- The 5-year median for Receivables is $29.6 million (2023), against an average of $29.2 million.
- The sharpest annual moves came in 2022 and 2024: Receivables soared 115.81% in 2022, then decreased 24.83% in 2024.
- Pacific Biosciences Of California's Receivables stood at $18.8 million in 2022, then jumped by 94.91% to $36.6 million in 2023, then decreased by 24.83% to $27.5 million in 2024, then climbed by 28.79% to $35.4 million in 2025, then dropped by 17.2% to $29.4 million in 2026.
- Business Quant data shows PACB's Receivables at $29.4 million in Q1 2026, $35.4 million in Q4 2025, and $30.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Pacific Biosciences Of California | 397.95 Mn | 161.08 Mn | 12.64 Mn | 31.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.10 Mn |
| Mar 31, 2026 | 29.35 Mn |
| Dec 31, 2025 | 35.45 Mn |
| Sep 30, 2025 | 30.62 Mn |
| Jun 30, 2025 | 32.26 Mn |
| Mar 31, 2025 | 31.65 Mn |
| Dec 31, 2024 | 27.52 Mn |
| Sep 30, 2024 | 29.38 Mn |
| Jun 30, 2024 | 32.43 Mn |
| Mar 31, 2024 | 30.32 Mn |
| Dec 31, 2023 | 36.62 Mn |
| Sep 30, 2023 | 30.49 Mn |
| Jun 30, 2023 | 24.03 Mn |
| Mar 31, 2023 | 29.59 Mn |
| Dec 31, 2022 | 18.79 Mn |
| Sep 30, 2022 | 22.76 Mn |
| Jun 30, 2022 | 27.06 Mn |
| Mar 31, 2022 | 27.85 Mn |
| Dec 31, 2021 | 24.24 Mn |
| Jun 30, 2021 | 19.94 Mn |